Please make JavaScript on and see this site.
● Presented Powerpoint (in pdf)
Thu. October 12
Chair: Mr. Shuuichi Kishida, Senior Executive Director, PMDA
13:30～13:45
Opening Remarks
Dr. Tatsuo Kurokawa, Councilor, Minister's Secretariat, MHLW (Japan)
13:45～14:15
The Impact of Global Development: a US FDA Perspective
Dr. Murray M. Lumpkin, Deputy Commissioner, FDA (USA)
14:15～14:45
Global Development of Drugs and Co-operation among Asian Economies
Dr. Chi-Chou Liao,
Director General, Bureau of Pharmaceutical Affairs,
14:45～15:15
Role of Japan and Asian Countries in the Global Pharmaceutical Development
Mr. Akira Miyajima, Chief Executive, PMDA (Japan)
15:15～15:45
Coffee Break
Chair: Mr. Akira Kawahara, Chief Safety Officer, PMDA
15:45～16:15
Recent Development of ICH GCG
Dr. Minoru Kubota, Chairman, ICH Project Committee, JPMA (Japan)
16:15～16:45
The Continuing History of the Safety of Medicines
Prof. Sir Alasdair M. Breckenridge, Chairman, MHRA (UK)
16:45～17:15
Combination Products and Asia Regional Medical Device Regulatory Harmonization
Mr. Michael B. Gropp,
Vice President, Global Regulatory and Public Policy,
19:00～21:00
Reception
Fri. October 13 AM
Session and Panel Discussion on Global Development in Asia
Chair: Dr. Toshiyoshi Tominaga,
International Planning Director (Pharmaceutical Affairs),
9:00～9:20
Global Development in Asia: a PhRMA Perspective
Mr. Harrison C. Cook, Co-chair, JTC, Ph RMA (USA)
9:20～9:40
Global Develoment in Asia - a JPMA perspective -
Mr. Hironobu Saito,
Senior Vice Director, Clinical Development Department &
9:40～10:00
Global Development in Asia: The Singapore Perspective
Dr. John Lim, Chief Executive Officer, HSA (Singapore)
10:00～10:20
Global Clinical Trials in Korea
Dr. In-Sook Park,
Deputy Director, Narcotic and Neuropharmacological
10:20～10:50
Coffee Break
10:50～11:10
Global Development in Chinese Taipei
Dr. Herng-der Chern, Executive Director, CDE (Chinese Taipei)
11:10～11:30
Global Development: Japanese Efforts and Views
Mr. Kazuhiko Mori, Associate Center Director, PMDA (Japan)
11:30～12:20
Panel Discussion
Fri. October 13 PM
Chair: Dr. Satoshi Toyoshima, Executive Director, PMDA (Japan)
14:20～14:50
EMEA's Views on Global Development
Mr. Thomas Lönngren, Executive Director, European Medicines Agency (EMEA)
14:50～15:20
ASEAN Harmonization
Dr. Yuppadee Javroongrit, Thai FDA (Thailand)
15:20～15:50
Coffee Break
15:50～16:20
Expectations of Asian Collaboration and Contribution to New Medicines
Mr. Kazuhiko Nakajima, Chairperson of Drug Evaluation committee, JPMA (Japan)
16:20～16:50
Summary Report APEC 2006
Dr. Satoshi Toyoshima, Executive Director, PMDA (Japan)
16:50～17:00
Closing Remarks
Mr. Toshiro Nakagaki,
Director, Evaluation and Licensing Division,
● Symposium scenes Click here >>
● Questionnaire Result Click here >>
Secretariat of APEC 2006 PH
